Breaking News Instant updates and real-time market news.

IR

Ingersoll-Rand

$53.96 /

-0.525 (-0.96%)

20:35
10/26/21
10/26
20:35
10/26/21
20:35

Ingersoll-Rand initiates quarterly dividend of 2c per share

The dividend is payable on December 17, 2021, to stockholders of record on November 10, 2021. The company states: "This is the first quarterly dividend to be paid by the company as part of its new dividend program, which was recently announced during the presentation of its M&A-focused capital allocation strategy at an investor call on September 2, 2021."

  • 04

    Nov

  • 18

    Nov

  • 11

    May

  • 04

    Aug

IR Ingersoll-Rand
$53.96 /

-0.525 (-0.96%)

10/07/21 Wells Fargo
Ingersoll-Rand initiated with an Equal Weight at Wells Fargo
09/27/21 BofA
SPX Flow reinstated with Underperform at BofA after board rejects offer
09/10/21 Morgan Stanley
Ingersoll-Rand resumed with an Overweight at Morgan Stanley
09/03/21
Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Hot Stocks
Viatris announces appeals court upholds invalidation of Biogen Tecfidera patent » 07:04
12/01/21
12/01
07:04
12/01/21
07:04
VTRS

Viatris

$12.32 /

-0.19 (-1.52%)

, BIIB

Biogen

$235.67 /

-0.68 (-0.29%)

Viatris (VTRS) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VTRS Viatris
$12.32 /

-0.19 (-1.52%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

VTRS Viatris
$12.32 /

-0.19 (-1.52%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
BIIB Biogen
$235.67 /

-0.68 (-0.29%)

11/30/21 Wedbush
Wedbush keeps Neutral rating on Biogen after court denies appeal in patent case
11/18/21 BMO Capital
Biogen initiated with an Outperform at BMO Capital
11/17/21 Cowen
Cowen says Biogen negative vote at CHMP 'disappointing, but far from surprising'
11/17/21 Stifel
Biogen shares weren't really pricing in Europe approval, says Stifel
VTRS Viatris
$12.32 /

-0.19 (-1.52%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

VTRS Viatris
$12.32 /

-0.19 (-1.52%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

Hot Stocks
Future FinTech signs LOI to develop metaverse platform » 07:03
12/01/21
12/01
07:03
12/01/21
07:03
FTFT

Future FinTech

$1.57 /

-0.035 (-2.19%)

Future FinTech signed a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FTFT Future FinTech
$1.57 /

-0.035 (-2.19%)

FTFT Future FinTech
$1.57 /

-0.035 (-2.19%)

Hot Stocks
Standard Lithium completes $100M direct investment from Koch Strategic Platforms » 07:03
12/01/21
12/01
07:03
12/01/21
07:03
SLI

Standard Lithium

$10.42 /

-0.46 (-4.23%)

Standard Lithium…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLI Standard Lithium
$10.42 /

-0.46 (-4.23%)

SLI Standard Lithium
$10.42 /

-0.46 (-4.23%)

10/13/21 Stifel
Standard Lithium upgraded to Buy from Hold at Stifel
10/13/21 Canaccord
Standard Lithium price target raised to C$14 from C$9.25 at Canaccord
10/13/21 Canaccord
Standard Lithium upgraded to Speculative Buy from Hold at Canaccord
08/12/21 Canaccord
Standard Lithium downgraded to Hold from Speculative Buy at Canaccord
SLI Standard Lithium
$10.42 /

-0.46 (-4.23%)

SLI Standard Lithium
$10.42 /

-0.46 (-4.23%)

SLI Standard Lithium
$10.42 /

-0.46 (-4.23%)

Recommendations
Zscaler price target raised to $415 from $325 at Baird » 07:03
12/01/21
12/01
07:03
12/01/21
07:03
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Baird analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

06:59 Today Wolfe Research
Zscaler price target raised to $400 from $325 at Wolfe Research
06:55 Today Deutsche Bank
Zscaler price target raised to $430 from $400 at Deutsche Bank
06:49 Today UBS
Zscaler price target raised to $380 from $295 at UBS
06:47 Today Mizuho
Zscaler price target raised to $400 from $385 at Mizuho
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Hot Stocks
BioXcel Therapeutics announces FDA extends review period of NDA for BXCL501 » 07:02
12/01/21
12/01
07:02
12/01/21
07:02
BTAI

BioXcel Therapeutics

$22.91 /

+0.67 (+3.01%)

BioXcel Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$22.91 /

+0.67 (+3.01%)

BTAI BioXcel Therapeutics
$22.91 /

+0.67 (+3.01%)

11/16/21 Canaccord
BioXcel Therapeutics weakness a buying opportunity, says Canaccord
11/15/21
Fly Intel: Top five analyst downgrades
11/15/21 Goldman Sachs
BioXcel Therapeutics downgraded to Sell from Buy at Goldman Sachs
08/19/21 Canaccord
BioXcel Therapeutics weakness a buying opportunity, says Canaccord
BTAI BioXcel Therapeutics
$22.91 /

+0.67 (+3.01%)

  • 23
    Jun
BTAI BioXcel Therapeutics
$22.91 /

+0.67 (+3.01%)

Initiation
Vertex Energy initiated with an Outperform at Credit Suisse » 07:01
12/01/21
12/01
07:01
12/01/21
07:01
VTNR

Vertex Energy

$4.93 /

-0.005 (-0.10%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VTNR Vertex Energy
$4.93 /

-0.005 (-0.10%)

VTNR Vertex Energy
$4.93 /

-0.005 (-0.10%)

11/09/21 Craig-Hallum
Vertex Energy price target lowered to $18 from $25 at Craig-Hallum
06/30/21 Craig-Hallum
Vertex Energy price target raised to $25 from $13 at Craig-Hallum
06/01/21 Stifel
Vertex Energy price target raised to $17 from $2 at Stifel
05/28/21 H.C. Wainwright
Vertex Energy price target raised to $25 from $4 at H.C. Wainwright
VTNR Vertex Energy
$4.93 /

-0.005 (-0.10%)

VTNR Vertex Energy
$4.93 /

-0.005 (-0.10%)

VTNR Vertex Energy
$4.93 /

-0.005 (-0.10%)

Hot Stocks
ASE Technology to sell shares, equity interest in GAPT Holding for $1.46B » 07:01
12/01/21
12/01
07:01
12/01/21
07:01
ASX

ASE Technology

$7.31 /

-0.11 (-1.48%)

ASE Technology announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASX ASE Technology
$7.31 /

-0.11 (-1.48%)

ASX ASE Technology
$7.31 /

-0.11 (-1.48%)

10/28/21 KGI Securities
ASE Technology downgraded to Neutral from Outperform at KGI Securities
10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 Goldman Sachs
ASE Technology downgraded to Neutral from Buy at Goldman Sachs
06/25/21 Nomura
ASE Technology downgraded to Neutral from Buy at Nomura
ASX ASE Technology
$7.31 /

-0.11 (-1.48%)

ASX ASE Technology
$7.31 /

-0.11 (-1.48%)

Recommendations
TG Therapeutics price target lowered to $54 from $70 at Cantor Fitzgerald » 07:01
12/01/21
12/01
07:01
12/01/21
07:01
TGTX

TG Therapeutics

$15.21 /

-8.15 (-34.89%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TGTX TG Therapeutics
$15.21 /

-8.15 (-34.89%)

TGTX TG Therapeutics
$15.21 /

-8.15 (-34.89%)

06:07 Today H.C. Wainwright
TG Therapeutics price target lowered to $75 from $84 at H.C. Wainwright
11/15/21 Goldman Sachs
TG Therapeutics downgraded to Sell from Neutral at Goldman Sachs
11/10/21 Cantor Fitzgerald
TG Therapeutics price target lowered to $70 from $74 at Cantor Fitzgerald
08/03/21 B. Riley
TG Therapeutics price target lowered to $63 from $91 at B. Riley
TGTX TG Therapeutics
$15.21 /

-8.15 (-34.89%)

  • 15
    Dec
TGTX TG Therapeutics
$15.21 /

-8.15 (-34.89%)

Periodicals
Microsoft shareholders approve sexual harassment disclosure proposal, WSJ says » 07:00
12/01/21
12/01
07:00
12/01/21
07:00
MSFT

Microsoft

$330.66 /

-5.88 (-1.75%)

Microsoft shareholders…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

11/22/21 Wells Fargo
Wells Fargo starts Microsoft with Overweight, $400 target on 'bright future'
11/22/21 Wells Fargo
Microsoft initiated with an Overweight at Wells Fargo
11/19/21 UBS
Zoom Video price target lowered to $285 from $315 at UBS
11/16/21 Credit Suisse
Microsoft assumed with an Outperform at Credit Suisse
MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

MSFT Microsoft
$330.66 /

-5.88 (-1.75%)

Earnings
Build-A-Bear sees FY21 $390M-$400M, one estimate $382.91M » 07:00
12/01/21
12/01
07:00
12/01/21
07:00
BBW

Build-A-Bear

$17.01 /

-0.02 (-0.12%)

Sees EBITDA $55M-$60M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

Recommendations
Ambarella price target raised to $200 from $125 at Baird » 06:59
12/01/21
12/01
06:59
12/01/21
06:59
AMBA

Ambarella

$180.08 /

-1.835 (-1.01%)

Baird analyst Tristan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

06:54 Today Deutsche Bank
Ambarella price target raised to $155 from $115 at Deutsche Bank
11/29/21 Morgan Stanley
Ambarella price target raised to $222 from $137 at Morgan Stanley
10/27/21 Needham
Ambarella price target raised to $220 from $140 at Needham
10/27/21 Roth Capital
Ambarella price target raised to $225 from $170 at Roth Capital
AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

Recommendations
Zscaler price target raised to $400 from $325 at Wolfe Research » 06:59
12/01/21
12/01
06:59
12/01/21
06:59
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

06:55 Today Deutsche Bank
Zscaler price target raised to $430 from $400 at Deutsche Bank
06:49 Today UBS
Zscaler price target raised to $380 from $295 at UBS
06:47 Today Mizuho
Zscaler price target raised to $400 from $385 at Mizuho
06:30 Today BTIG
Zscaler price target raised to $439 from $401 at BTIG
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Recommendations
Kimco Realty price target raised to $24 from $23 at Baird » 06:58
12/01/21
12/01
06:58
12/01/21
06:58
KIM

Kimco Realty

$22.43 /

-0.85 (-3.65%)

Baird analyst Wesley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KIM Kimco Realty
$22.43 /

-0.85 (-3.65%)

KIM Kimco Realty
$22.43 /

-0.85 (-3.65%)

11/22/21 Evercore ISI
Kimco Realty upgraded to Outperform from In Line at Evercore ISI
11/22/21 Stifel
Kimco Realty upgraded to Buy from Hold at Stifel
09/23/21 Wolfe Research
Kimco Realty initiated with a Peer Perform at Wolfe Research
09/23/21 Wolfe Research
Kimco Realty initiated with a Peer Perform at Wolfe Research
KIM Kimco Realty
$22.43 /

-0.85 (-3.65%)

Earnings
Build-A-Bear reports Q3 adjusted EPS 38c, one estimate (17c) » 06:58
12/01/21
12/01
06:58
12/01/21
06:58
BBW

Build-A-Bear

$17.01 /

-0.02 (-0.12%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

Recommendations
Latham Group price target raised to $26 from $25 at Baird » 06:56
12/01/21
12/01
06:56
12/01/21
06:56
SWIM

Latham Group

$25.76 /

+2.3 (+9.80%)

Baird analyst Timothy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWIM Latham Group
$25.76 /

+2.3 (+9.80%)

SWIM Latham Group
$25.76 /

+2.3 (+9.80%)

05:58 Today Barclays
Latham Group price target raised to $30 from $26 at Barclays
11/11/21 BofA
Latham Group upgraded to Buy from Neutral at BofA
11/11/21 Barclays
Latham Group price target raised to $26 from $23 at Barclays
11/08/21 BofA
Latham Group initiated with a Neutral at BofA
SWIM Latham Group
$25.76 /

+2.3 (+9.80%)

  • 23
    Apr
Syndicate
Longeveron raises $20.5M in a private placement » 06:56
12/01/21
12/01
06:56
12/01/21
06:56
LGVN

Longeveron

$26.01 /

-0.08 (-0.31%)

Longeveron announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LGVN Longeveron
$26.01 /

-0.08 (-0.31%)

LGVN Longeveron
$26.01 /

-0.08 (-0.31%)

  • 12
    Feb
Recommendations
Zscaler price target raised to $430 from $400 at Deutsche Bank » 06:55
12/01/21
12/01
06:55
12/01/21
06:55
ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

06:49 Today UBS
Zscaler price target raised to $380 from $295 at UBS
06:47 Today Mizuho
Zscaler price target raised to $400 from $385 at Mizuho
06:30 Today BTIG
Zscaler price target raised to $439 from $401 at BTIG
06:14 Today JMP Securities
Zscaler price target raised to $400 from $330 at JMP Securities
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

Recommendations
Salesforce price target lowered to $315 from $330 at UBS » 06:55
12/01/21
12/01
06:55
12/01/21
06:55
CRM

Salesforce

$285.03 /

-11.56 (-3.90%)

UBS analyst Karl…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

06:51 Today Deutsche Bank
Salesforce earnings selloff a buying opportunity, says Deutsche Bank
06:49 Today Mizuho
Salesforce price target lowered to $350 from $360 at Mizuho
11/23/21 BofA
Salesforce price target raised to $360 from $330 at BofA
11/23/21 Jefferies
Salesforce price target raised to $360 from $325 at Jefferies
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

Hot Stocks
Sanofi to acquire Origimm Biotechnology to add ORI-001 to early-stage pipeline » 06:54
12/01/21
12/01
06:54
12/01/21
06:54
SNY

Sanofi

$47.61 /

-0.6 (-1.24%)

Sanofi announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

11/01/21 HSBC
Sanofi upgraded to Buy from Hold at HSBC
10/25/21 H.C. Wainwright
Regeneron trial data reinforce bullish outlook on Dupixent, says H.C. Wainwright
10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

SNY Sanofi
$47.61 /

-0.6 (-1.24%)

Recommendations
Ambarella price target raised to $155 from $115 at Deutsche Bank » 06:54
12/01/21
12/01
06:54
12/01/21
06:54
AMBA

Ambarella

$180.08 /

-1.835 (-1.01%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

11/29/21 Morgan Stanley
Ambarella price target raised to $222 from $137 at Morgan Stanley
10/27/21 Needham
Ambarella price target raised to $220 from $140 at Needham
10/27/21 Roth Capital
Ambarella price target raised to $225 from $170 at Roth Capital
10/27/21 Stifel
Ambarella price target raised to $200 after Oculii deal at Stifel
AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

Periodicals
23andMe develops immuno-oncology drugs with SPAC cash, WSJ reports » 06:54
12/01/21
12/01
06:54
12/01/21
06:54
ME

23andMe

$8.18 /

-0.67 (-7.57%)

, GSK

GlaxoSmithKline

$41.14 /

-0.225 (-0.54%)

23andMe Holding (ME), the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ME 23andMe
$8.18 /

-0.67 (-7.57%)

GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

ME 23andMe
$8.18 /

-0.67 (-7.57%)

11/14/21 Citi
23andMe downgraded to Neutral from Buy at Citi
08/16/21 Credit Suisse
23andMe initiated with an Outperform at Credit Suisse
08/16/21 Citi
23andMe price target lowered to $12 from $14 at Citi
07/13/21 Citi
23andMe initiated with a Buy at Citi
GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

11/30/21 H.C. Wainwright
Vir Biotechnology price target raised to $200 from $135 at H.C. Wainwright
11/24/21 Berenberg
GlaxoSmithKline price target raised to 1,630 GBp from 1,540 GBp at Berenberg
11/08/21 UBS
GlaxoSmithKline price target raised to 1,500 GBp from 1,460 GBp at UBS
11/05/21 Barclays
GlaxoSmithKline upgraded to Equal Weight from Underweight at Barclays
ME 23andMe
$8.18 /

-0.67 (-7.57%)

GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

ME 23andMe
$8.18 /

-0.67 (-7.57%)

GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

ME 23andMe
$8.18 /

-0.67 (-7.57%)

GSK GlaxoSmithKline
$41.14 /

-0.225 (-0.54%)

Recommendations
NetApp price target raised to $92 from $86 at Deutsche Bank » 06:53
12/01/21
12/01
06:53
12/01/21
06:53
NTAP

NetApp

$89.00 /

-2.545 (-2.78%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTAP NetApp
$89.00 /

-2.545 (-2.78%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

06:22 Today Citi
Citi cuts HP Enterprise target, opens pair trade with NetApp
11/24/21 Morgan Stanley
Dell Technologies price target raised to $68 from $67 at Morgan Stanley
10/18/21 Goldman Sachs
NetApp downgraded to Sell from Neutral at Goldman Sachs
10/14/21 Citi
NetApp upgraded to Buy from Sell at Citi
NTAP NetApp
$89.00 /

-2.545 (-2.78%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

Hot Stocks
Roche completes purchase agreement with TIB Molbiol » 06:52
12/01/21
12/01
06:52
12/01/21
06:52
RHHBY

Roche

$48.78 /

+0.45 (+0.93%)

Roche announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$48.78 /

+0.45 (+0.93%)

RHHBY Roche
$48.78 /

+0.45 (+0.93%)

10/21/21 Benchmark
Biogen, Roche calls 'not helpful for Ionis story,' says Benchmark
10/19/21 William Blair
William Blair says Atea MOONSONG results raise concerns, but plunge 'premature'
10/13/21 Morgan Stanley
Roche price target raised to CHF 380 from CHF 370 at Morgan Stanley
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
RHHBY Roche
$48.78 /

+0.45 (+0.93%)

RHHBY Roche
$48.78 /

+0.45 (+0.93%)

RHHBY Roche
$48.78 /

+0.45 (+0.93%)

Recommendations
GlobalFoundries price target raised to $78 from $75 at Deutsche Bank » 06:52
12/01/21
12/01
06:52
12/01/21
06:52
GFS

GlobalFoundries

$69.42 /

-1.05 (-1.49%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

11/22/21
Fly Intel: Top five analyst initiations
11/22/21 HSBC
GlobalFoundries initiated with a Hold at HSBC
11/22/21 BofA
BofA starts GlobalFoundries at Buy, sees 40% upside potential
11/22/21 JPMorgan
GlobalFoundries initiated with an Overweight at JPMorgan
GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

  • 28
    Oct
GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

Hot Stocks
Northern Dynasty comments on EPA press release regarding Pebble Project » 06:52
12/01/21
12/01
06:52
12/01/21
06:52
NAK

Northern Dynasty

/

+

Northern Dynasty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NAK Northern Dynasty
/

+

NAK Northern Dynasty
/

+

02/11/21 H.C. Wainwright
Northern Dynasty price target raised to $1.20 from 80c at H.C. Wainwright
12/04/20 H.C. Wainwright
Northern Dynasty price target lowered to 80c from $3.25 at H.C. Wainwright
NAK Northern Dynasty
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.